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ING1b negatively regulates HIF1α protein levels in
adipose-derived stromal cells by a SUMOylation-
dependent mechanism
N Bigot1,2,3, C Guérillon1,2,3, S Loisel1,2,3, N Bertheuil2,4, L Sensebé5,6,7, K Tarte1,2,3,4 and R Pedeux*,1,2,3
Hypoxic niches help maintain mesenchymal stromal cell properties, and their amplification under hypoxia sustains their immature
state. However, how MSCs maintain their genomic integrity in this context remains elusive, since hypoxia may prevent proper DNA
repair by downregulating expression of BRCA1 and RAD51. Here, we find that the ING1b tumor suppressor accumulates in
adipose-derived stromal cells (ADSCs) upon genotoxic stress, owing to SUMOylation on K193 that is mediated by the E3 small
ubiquitin-like modifier (SUMO) ligase protein inhibitor of activated STAT protein γ (PIAS4). We demonstrate that ING1b finely
regulates the hypoxic response by triggering HIF1α proteasomal degradation. On the contrary, when mutated on its SUMOylation
site, ING1b failed to efficiently decrease HIF1α levels. Consistently, we observed that the adipocyte differentiation, generally
described to be downregulated by hypoxia, was highly dependent on ING1b expression, during the early days of this process.
Accordingly, contrary to what was observed with HIF1α, the absence of ING1b impeded the adipogenic induction under hypoxic
conditions. These data indicate that ING1b contributes to adipogenic induction in adipose-derived stromal cells, and thus hinders
the phenotype maintenance of ADSCs.
Cell Death and Disease (2015) 6, e1612; doi:10.1038/cddis.2014.577; published online 22 January 2015
Human mesenchymal stem/stromal cells (MSCs) are able to
self-renew and differentiate into various cell types. Recently,
MSCs have been developed as tools for tissue engineering
and cell-based therapies1 in particular owing to their trophic
and immunosuppressive activities.2 Conventionally, the bone
marrow MSCs (BM-MSCs) and the adipose-derived stem/
stromal cells (ADSCs) have constituted the main sources of
MSCs for clinical use. These cells are expanded in vitro prior to
their application; however, this long-term culture may allow the
emergence of senescence and phenotypic alterations,
rendering MSCs unsuitable for clinical purposes.3
To overcome these issues, MSC culture in conditions
mimicking hypoxic niches has been tested.4 LowO2 tensions
promote MSC growth, survival and maintain their self-
renewing multipotent state.5 However, how hypoxia (1% O2)
affects MSC behavior is unclear. Responses to hypoxia
are mainly mediated by hypoxia inducible factors (HIFs).
HIF1, 2 and 3α subunits, are constitutively degraded in
normoxia and stabilized in hypoxia. Consequently, when
stabilized they can dimerize with HIF1β, and then translocate
into the nucleus to modulate the expression of selected genes.
HIF1α is highly expressed in MSCs, controls their metabolic
fate and maintains them in an undifferentiated state.6 HIF1α
has also been shown to delay the occurrence of senescence in
MSCs, by repressing E2A and p21 expression.7
The inhibitors of growth (ING) family genes act as readers of
the epigenetic histone code. Among them, ING1 has been
described as a type II tumor suppressor, regulating cell
growth, DNA repair, apoptosis, chromatin remodeling and
senescence.8 To some extent, ING1 and HIF might have
opposite effects, (e.g. on tumor progression). Indeed,
HIF1α, unlike ING1 that inhibits angiogenesis, promotes
angiogenesis.9 Furthermore, p53, a well-known ING1b inter-
actor, and HIF1α have been shown in several studies to have
antagonistic effects. Following DNA damage, p53 induces
apoptosis and inhibits survival of cells by reducing activity and
levels of HIF1α.10,11
So far, ING4 has been shown as the only ING protein to
regulate the hypoxic response. Indeed, by interacting with HIF
prolyl hydroxylase 2 (HPH-2), ING4 has been described to
repress some HIF1α activities under hypoxic conditions.12
Here, we show that ING1b accumulates in ADSCs following
DNA damage in hypoxia. According to the opposing roles of
ING1b and HIF1α, we hypothesized that ING1b could interfere
with HIF1α and participate in the conservation of the genomic
integrity of MSCs. Mechanistically, we found that ING1b
interacted with HIF1α and promoted its proteasomal degrada-
tion in hypoxia. SUMOylation of ING1b played a role since the
unSUMOylated form of ING1b was unable to trigger HIF1α
degradation. The E3 small ubiquitin-like modifier (SUMO)
ligase protein inhibitor of activated STAT protein γ (PIAS4)
1INSERM U917, Microenvironnement et Cancer, Rennes, France; 2Université de Rennes 1, Rennes, France; 3Etablissement Français du Sang Bretagne, Rennes, France;
4Service ITeCH, CHU Pontchaillou, Rennes, France; 5Etablissement Français du Sang Pyrénées Méditerranée; 6Université Paul Sabatier, Toulouse, France and
7UMR5273-INSERM U1031, Toulouse, France
*Corresponding author: R Pedeux, Université de Rennes 1, Bâtiment 2, Pièce 117, 2 avenue du Professeur Léon Bernard, Rennes 35043, France. Tel: +33 (0)2 23 23 47 02;
Fax: +33 (0)2 23 23 49 58; E-mail: remy.pedeux@univ-rennes1.fr
Received 03.7.14; revised 18.11.14; accepted 03.12.14; Edited by S Lavandero
Abbreviations: HIF1α, hypoxia inducible factor 1 alpha; ING, inhibitor of growth; SUMO, small ubiquitin-like modifier; PIAS4, protein inhibitor of activated STAT protein γ;
ADSC, adipose-derived stromal cell
Citation: Cell Death and Disease (2015) 6, e1612; doi:10.1038/cddis.2014.577
& 2015 Macmillan Publishers Limited All rights reserved 2041-4889/15
www.nature.com/cddis
participated in HIF1α degradation and ING1b accumulation
following a genotoxic stress in 1% O2. ING1b, subsequently,
took part in decreasing PIAS4 levels after DNA damage.
Finally, we report that ING1b by decreasing HIF1α level
modulated ADSC differentiation potential. These data indicate
that ING1b, according to its SUMOylation status, regulates the
hypoxic response by contributing to the HIF1α degradation,
and therefore may impede HIF1α-related effects on the
maintenance of ADSCs stem cell character.
Results
ING1b protein levels increase following genotoxic stress
in ADSCs cultured under hypoxic conditions. At first, we
aimed at evaluating the behavior of MSCs in response to
DNA damage, in normoxia and hypoxia. For that purpose, we
used fully characterized ADSCs isolated from human
lipoaspirates (Supplementary Figure 1). Over 98% of cells
were positive for CD90 and CD73 ando2% were positive for
CD31 and CD4513 (Figure 1a). To investigate the associated
effects of variable O2 tensions and genotoxic stress on
ADSCs, we placed them either under 21% O2 or under 1%
O2, in the presence of doxorubicin (Figure 1b). As expected,
HIF1α accumulated in hypoxic ADSCs but its expression
decreased after the induction of DNA damage, while we
observed an increase of ING1b. Following ING1 silencing,
ADSCs displayed greater HIF1α protein levels in hypoxia,
arguing for a specific relationship between HIF1α and ING1b
(Figure 2a). Interestingly, ING1b knockdown led to HIF1α
increase in normoxia as well (Figure 2b). These effects did
not appear to be dependent on ING4, since ING1 silencing
had no noticeable effect on ING4 expression (Supplementary
Figure 2). The ING1b depletion did not affect HIF1α mRNA
levels 48 h after siRNA transfection, suggesting that HIF1α
regulation by ING1b may occur later at the mRNA level or
rather at the protein level (Figure 2d). This inverse relation-
ship between ING1b and HIF1α was confirmed using
transient overexpression of ING1b in ADSCs under hypoxic
conditions, leading to a decrease of HIF1α (Figure 2c).
Together, these findings suggest that under hypoxic condi-
tions, in response to a genotoxic stress, ING1b may trigger
HIF1α degradation in ADSCs.
SUMOylation of ING1b triggers HIF1α degradation. We
hypothesized that the ING1b effect on HIF1α may be
associated with post-translational modifications. Indeed, the
phosphorylation of ING1b is needed for its activity and
stabilization.14 Recently, ING1 was seen to be SUMOylated
on K193,15 and we demonstrated that ING1b may be mono or
diSUMOylated in ADSCs as well (Supplementary Figure 3).
On the other hand, data on HIF1α SUMOylation are scarce,
and the consequences of this modification remain
unclear.16,17 Accordingly, we thought that ING1b SUMOyla-
tion could be required for its HIF1α pro-degrading effects.
A SUMOylation site prediction tool (SUMOplot Analysis
Program http://www.abgent.com/sumoplot) identified the AKAE
motif (192–195), located at the junction of the last nucleolar
targeting sequence of the NLS domain and the REASP
amino acid motif. As a consequence, a SUMOylation
defective mutant was generated and named ING1b E195A
(Figure 3a). In U2OS cells, ING1b expression is higher than
in ADSCs (Supplementary Figure 4). As observed in ADSCs,
HIF1α protein levels under hypoxic conditions increased in
untransfected U2OS cells (Figure 3b) and a knockdown for
ING1b led to an increase of HIF1α as well (Figure 3c).
Moreover U2OS cells are easier to transfect than ADSCs.
Therefore, U2OS were used to study the interactions of
ING1b with HIF1α. Thus, U2OS cells were chosen to be
stably transfected with pcDNA 3.1 ING1b WT or pcDNA 3.1
ING1b E195A constructs, to use a model that express
moderate levels of ING1b WT or ING1b E195A proteins.
Interestingly, in hypoxia, U2OS harboring ING1b WT exhib-
ited low HIF1α levels, compared with ING1b E195A, which
failed to efficiently trigger HIF1α degradation (Figure 3d).
Furthermore, ING1b E195A strongly interacted with HIF1α
under hypoxic conditions compared with ING1b WT
(Figure 3f). Assuming this lack of detectable protein interac-
tions between ING1b WT and HIF1α might be due to a rapid
degradation by the proteasome (Figure 3e), HIF1α immuno-
precipitation was performed in the presence of the MG132
proteasome inhibitor (Figure 3g). By impeding proteasomal
activity, the interaction between the ING1b WT and HIF1α
proteins was detected.
The immunoprecipitation experiments suggested that
ING1b E195A, unlike ING1b WT, might maintain interactions
with HIF1α. This indicates that as long as ING1b is not
Figure 1 Adipose derived stromal cells (ADSCs) express higher levels of ING1b in hypoxia following genotoxic stress. (a) Characterization of ADSCs at P1. Expression level
is expressed as a percentage of positive cells targeted for CD90, CD73, CD31 and CD45 compared with their isotypic controls (mean±S.D., n= 3). (b) ING1b increases while
HIF1α decreases in ADSCs under hypoxia. ADSCs were incubated for 24 h in normoxia (21% O2) or hypoxia (1% O2) (indicated by a ‘–’ and a ‘+’, respectively), prior to a
doxorubicin treatment (Dox) at a final concentration of 10 μM for 3 h. Cells were maintained in normoxia or hypoxia, and harvested 24 h later. Whole-cell extracts were fractionated
by SDS-PAGE and probed with the indicated antibodies. The Western blot shown is a representative figure of three experiments
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SUMOylated, interactions with HIF1α are conserved under
hypoxic conditions and therefore may prevent degradation
The PIAS4-dependent stabilization of ING1b promotes
PIAS4 decrease in return. Since we have recently
described that the E3 conjugating enzyme PIAS4 partici-
pated in the ING1b SUMOylation,15 we hypothesized that
PIAS4 could be involved in the shift from a conservation to a
degradation of HIF1α by regulating ING1b. We therefore
investigated the role of PIAS4, a SUMO E3 ligase character-
ized to enhance ING1 SUMOylation and its activity,15 but also
described to regulate HIF1α.16,18 In Figures 4a and b, we
showed that under hypoxic conditions, the induction of a
genotoxic stress increased ING1b levels and led to a
decrease of PIAS4 (Figure 4a, lane 2). Interestingly, a PIAS4
knockdown reduced ING1b protein levels in hypoxia after
doxorubicin treatment, suggesting that ING1b accumulation
in ADSCs relied on PIAS4 (Figure 4a, lane 4).19 By contrast,
we observed that ADSCs submitted to an ING1b knockdown
displayed increased PIAS4 levels in control cases and it was
also the case following doxorubicin treatment but to a lesser
extent (Figure 4b). Then, we aimed to determine whether the
PIAS4 decrease, related to the genotoxic stress in hypoxia,
could be dependent on ING1b. Thus, we managed to block
the protein translation with cycloheximide and we evaluated if
the doxorubicin treatment could modulate PIAS4 protein
levels (Figure 4c). By inhibiting the protein translation, we
noticed a PIAS4 protein decrease following the doxorubicin
treatment, but also that PIAS4 protein levels were less
impaired when ING1b was knocked down. This suggested
that doxorubicin reduced PIAS4 at a protein level through
ING1b activities and that increasing levels of ING1b might
oppose to PIAS4 (Figure 4c). In a same manner, U2OS cells
expressing ING1b WT, tended to feature lower amounts of
PIAS4 compared with the ING1b E195A expressing cells in
hypoxia (Figure 4d). Altogether, these data suggest that the
increase of ING1b protein levels that occurs after this DNA
damage may be attributable to a prior PIAS4-dependent
SUMOylation. This then appears to allow the activated form
of ING1b to contribute to the reduction of PIAS4 protein
levels.
PIAS4 silencing leads to reduced HIF1α protein levels.
SUMOylation has been shown to be a post-translational
Figure 2 ING1b in hypoxia induces HIF1α protein degradation following genotoxic stress. (a) HIF1α increases when ING1b is depleted. ADSCs were incubated for 24 h in
hypoxia prior to ING1b knockdown. Forty-eight hours later cells were either incubated or not with Dox for 3 h. Twenty-four hours later, cells were harvested and proteins analyzed
as described in b. gH2AX marks DNA damage induced by doxorubicin. (b) ING1b knockdown in normoxia increases HIF1α levels. ADSCs were submitted to an ING1b targeting
siRNA under 1% O2 for 72 h. Samples were used as in a. (c) HIF1α protein levels are reduced when ING1b WT is overexpressed in ADSCs in hypoxia. Following 24 h in hypoxia,
ADSCs have been transiently transfected with either an empty pcDNA 3.1 vector or with the pcDNA 3.1 Flag ING1b WT plasmid in hypoxia. Twenty-four hours later, cells were
incubated for 3 h with Dox. Twenty-four hours later, whole-cell lysates were analyzed using Western blot. (d) HIF1α transcription is not modulated by ING1b in ADSCs. ADSCs
incubated or not in hypoxia were submitted to an ING1b silencing for 48 h. HIF1α and ING1b expressions were analyzed by RT Q-PCR. Each sample was normalized to U6 level.
Bars represent mean±S.E.M., n= 3, non significant (NS) Po0.01 (**) in an unpaired Student’s t-test. The Western blots shown are representative of three experiments
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Figure 3 ING1b and HIF1α interact with each other in hypoxia, but SUMOylated ING1b favors HIF1α degradation. (a) Protein structure of Human ING1b. Human ING1b WT
and non SUMOyable ING1b E195A proteins domains: NCR, novel conserved region; NLS, nuclear localization signal; PBD, partial bromo domain; PBR, polybasic region; PHD,
plant homeodomain; PIP, PCNA-interacting protein. (b) Untransfected U2OS cells express HIF1α in hypoxia. Whole-cell extracts from untransfected U2OS cells cultured for 24 h
in 1% O2 atmosphere were fractionated by SDS-PAGE and probed with the indicated antibodies. (c) ING1b induces HIF1α decrease in U2OS cells. Twenty-four hours after they
were incubated in hypoxia, wild-type U2OS cells were transfected with siRNAs targeting ING1b as described in Figure 1c. (d) HIF1α decreases in ING1b WToverexpressing
U2OS cells, while ING1b E195A rescues HIF1α protein levels. Stably transfected U2OS cells with pcDNA 3.1 (empty vector), pcDNA 3.1 ING1b WTor pcDNA 3.1 ING1b E195A
were cultured for 24 h in 1% O2. Cells were harvested, and whole-cell lysates were analyzed in Western blot. (e) An inhibition of the proteasomal activity in hypoxia leads to a
HIF1α increase and an ING1 decrease. Stably transfected ING1b WTand ING1b E195A U2OS cells were cultured for 24 h in hypoxia and then incubated with the proteasome
inhibitor MG132 (20 μM) for 24 h in hypoxia. Whole-cell lysates were used in Western blot experiments. (f and g) ING1b interacts with HIF1α in hypoxia. After 24 h in hypoxia,
U2OS cells stably transfected with ING1b WT, ING1b E195A or empty vector were collected for ING1b immunoprecipitations (f). To maintain sufficient HIF1α protein levels,
because of ING1b-related pro-degrading effects, U2OS cells were incubated again for 24 h with MG132 (20 μM) in hypoxia and HIF1α immunoprecipitations were performed (g).
All the Western blots shown are representative of three experiments
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modification altering the stability or activity of several factors
in the hypoxic pathway, including HIF1α. SUMOylation has
been described to either stabilize or enhance HIF1α
signaling,20 its transcriptional activity16,18,21 or to participate
in the proteasomal degradation of HIF1α in hypoxia.17,22
To clarify the role of PIAS4, ADSCs and U2OS cells were
knocked down for PIAS4 and treated with doxorubicin during
hypoxia. Thereby, we observed in ADSCs that ING1b
accumulation that is required for triggering HIF1α degrada-
tion, seems to be PIAS4 dependent following doxorubicin
Figure 4 ING1b and HIF1α stabilizations depend on PIAS4, but ING1b inhibits PIAS4 in return. (a) PIAS4 depletion leads to reduced ING1b and HIF1α protein levels.
Experiment was performed as in Figure 1c, except that PIAS4 was silenced. (b) ING1b knockdown increases PIAS4 protein levels in ADSCs cultured in hypoxia. Experiment was
designed as described in Figure 1c. (c) Decrease of PIAS4 protein levels, following doxorubicin treatment, depends on ING1b in ADSCs cultured in hypoxia. ADSCs were
incubated in 1% O2 for 24 h prior to ING1b knockdown. Twenty-four hours later, cells were submitted to doxorubicin treatment (Dox). Three hours later media were replaced with
media containing cycloheximide (10 μg/ml) or not for 0, 5 or 10 supplementary hours to inhibit translation. Whole-cell extracts were run in Western blot with the indicated
antibodies. gH2AX indicates the occurrence of DNA damage. (d) Stable expression of ING1b WT leads to decreased PIAS4 protein levels in U2OS. Stably transfected U2OS
cells expressing either ING1b WT or ING1b E195A were placed in hypoxia for 24 h. Whole-cell lysates were used in Western blot. (e) Defective ING1b SUMOylation mutant
maintains HIF1α protein levels after a PIAS4 silencing. Stably transfected U2OS cells were cultured in hypoxia for 24 h prior to a PIAS4 knockdown. Cells were harvested 48 h
later and samples were used in Western blot. All the Western blots shown are representative of three experiments
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treatment. However, this PIAS4 silencing slightly reduced the
HIF1α levels as well (Figure 4a, lane 3). Interestingly, the
doxorubicin deleterious effects on HIF1α were reduced in a
substantial way when PIAS4 was silenced compared with its
control (Figure 4a, lanes 2 and 4). In hypoxia, a PIAS4
knockdown in U2OS cells expressing ING1b WT and ING1b
E195A demonstrated that PIAS4 was required for the stability
of HIF1α (Figure 4e, lanes 1 and 2). Of note, in cells
expressing ING1b WT, depletion of PIAS4 had no effect on
HIF1α levels, hinting again that HIF1α depends on ING1b for
its degradation and PIAS4 for its stabilization (Figure 4e,
lanes 3 and 4). Low HIF1α level (lane 4), could be the result of
a balance between lower ING1b favoring HIF1α, and low
PIAS4 hindering HIF1α accumulation. Still, ING1b E195A
cells featured a less substantial HIF1α degradation when
PIAS4 was lacking, further suggesting that unSUMOylated
ING1b may maintain HIF1α, regardless of the HIF1α
SUMOylation status. Taken together, these results suggest
that HIF1α protein stability in hypoxia does not only rely on
ING1b levels, but also on ING1b SUMOylation, according to
PIAS4 silencing experiments. Moreover, PIAS4 appears to be
needed for HIF1α protein conservation as well following
doxorubicin treatment.
ING1b and HIF1α modulate ADSCs fate. HIF1α has been
described to reduce mesenchymal stromal cell commitment
to adipocyte differentiation.23 Therefore, we hypothesized
that the lack of ING1b in hypoxic context could increase
HIF1α levels, and subsequently impair differentiation pro-
cesses. To verify this hypothesis, we knocked down ING1b
expression and induced adipocyte differentiation. We
observed that ADSCs depleted for ING1b could not express
as much peroxisome proliferator-activated receptor γ2
(PPARγ2), lipoprotein lipase (LPL) or fatty acid binding
protein 4 (FABP4), as their respective controls, after 7 days
of adipogenic induction (Figure 5a). Conversely, HIF1α-
depleted cells expressed higher rates of these three
adipocyte markers. This argues that ING1b takes part in
adipocyte markers expressions while HIF1α prevents them.
When these experiments lasted up to 14 days, we observed
that adipogenesis still occurred after day 7, as judging by
increasing rates of late adipocyte markers, that is, FABP4 and
LPL. However, no significant difference was observed for
adipocyte markers expression between control and ING1b-
depleted cells (Figure 5d). Adipogenic induction experiments
were performed under normoxic conditions, a context more
prone to adipocyte differentiation until day 7. We observed
that this differentiation process was more efficient in normoxia
and, by contrast to hypoxic conditions, ING1 silencing did not
impair the adipocyte differentiation (Figure 5b,Supplementary
Figure 6). These findings suggest that during early adipo-
genic differentiation, hypoxia mediated a HIF1α-dependent
decrease of adipocyte commitment, and conversely ING1b
specifically favors expressions of adipocyte markers. Inter-
estingly, the concomitant silencing of ING1b and HIF1α led to
normal expression of adipocyte markers (Figure 5a). This
suggests that ING1b and HIF1αmay have opposite effects on
the early steps of adipogenic induction. Besides, after these
7 days of adipogenic induction, we observed that the
expression of delta-like homolog 1/preadipocyte factor-1
(DLK1/PREF-1) expression decreased in all the tested cases,
suggesting a loss in the mesenchymal character of ADSCs
(Supplementary Figure 5) and an efficient induction of
adipogenesis.24
Discussion
Long-term cultures expose MSCs to replicative stress or DNA
damage, which may result in a loss of their multipotency and
immunomodulatory properties, genomic instability and even-
tually senescence.25–27 However, most of these studies have
relied on culture protocols using normoxia (21% O2). Culture
of MSCs under hypoxic conditions, reproducing hypoxic
niches, has been suggested as a way to maintain their
immature phenotype28 and to delay senescence. However,
hypoxia has also been demonstrated to induce a form of
replicative stress (o0.1% O2)29 and to hamper expression of
homologous recombination factors (Rad51 and BRCA1) in
cancer cell lines, BM-MSCs and in ADSCs.30–32
In this work, we first intended to assess whether ADSCs
were able to preserve their genomic integrity and decided to
evaluate possible roles of the ING1 protein. First, we observed
that following doxorubicin treatments in hypoxia (1% O2), only
ADSCs (‘population doubling level’o20) could increase their
ING1b protein levels, compared with U2OS cells. These
results are consistent with previous studies emphasizing that
the regulation of ING1b by DNA damage is not general, and
may be cell type or stimulus specific.14,33,34
We observed a decrease of HIF1α levels in ADSCs as a
result of an ING1b accumulation upon doxorubicin treatment.
Conversely, HIF1α levels increased in absence of ING1b.
Additional experiments revealed that HIF1α destabilization by
ING1b occurred at a protein level. This was also observed in
U2OS cells cultured in hypoxia with lowered HIF1α protein
levels in an ING1b-dependent manner. We show ING1b
interacts with HIF1α and promotes its degradation. ING1b is
known to prevent genomic stability through chromatin remo-
deling and cell cycle arrest34–36 in response to DNA damage.
ING1b as other ING proteins (ING2), is involved in the
regulation of replicative fork progression, particularly in lesion
bypass.37,38 Our data suggest that increasing ING1b levels,
observed in ADSCs following doxorubicin treatment, could
decrease the HIF1α protein levels, and consequently the
hypoxic response. Thus, ING1b may prevent the hypoxia-
mediated genomic instability by opposing to the HIF1α-
mediated transcriptional downregulation of proteins involved
in DNA repair.39,40 Nonetheless, the hypoxic response may be
regulated at different levels by different ING proteins. A
previous study demonstrated that HIF activities could be
modulated by ING412 (Figure 6e). Indeed, under hypoxic
conditions, stabilized HIF factors, which still interact with
HPH-2, allow the recruitment of ING4 to the promoters of HIF
target genes eventually preventing their expressions. Here,
the plant homeodomain of ING4 seemed required for its
interactions with HPH-2. Usually described to recognize
H3K4me2 or H3K4me3, the PHD appears to bind other
proteins, like HPH-2 or p65 in the case of ING4.41 Therefore,
an investigation on the ING1b PHD remains to be done for the
comprehension of the regulation of HIF1α, and eventually its
degradation. Besides, because this PHD is a common feature
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of the ING proteins, this suggests that other ING proteins:
ING2, ING3 and ING5 could play a role in the hypoxic
response as well.
We noticed that ING1b, when mutated on its SUMOylation
site, failed to trigger HIF1α degradation, suggesting that the
K193 SUMOylation site (mono or diSUMOylation) is required
for these effects. In addition, the E3 ligase PIAS4, involved in
ING1b SUMOylation seemed to be required for ING1b
increase following genotoxic stress.42 Our results also support
the study of Ceruti et al.,34 claiming that disconnects between
ING1 mRNA and protein levels following stimuli, like DNA
damage, depend on the existence of additional cellular
mechanisms that modulate ING1b levels. Interestingly, PIAS4
level was regulated in an ING1b-dependent manner. Indeed,
ING1b silencing was accompanied by increasing levels of
PIAS4 in ADSCs. Taken together, our results argue, at least
under hypoxia, PIAS4 and ING1b can regulate each other’s
activities. Moreover, ING1b may, through modulation of
PIAS4 activities, finely regulate HIF1α whose protein levels
appeared to rely on PIAS4 as well. Our results confirm that
post-translational modifications like SUMOylation (mono or
diSUMOylation), clearly modulate ING1 activities,14,43 and
suggest that SUMOylationmight be responsible for a shift from
a conserved ING1b/HIF1α complex to HIF1α degradation.
This indicates that ING1b SUMOylation may alter interactions
with HIF1α, either by masking binding sites or by a global
Figure 5 ING1b modulates adipogenesis process in hypoxia. ING1b and HIF1α have opposite effects on adipogenic differentiation of ADSCs until 7 days of induction.
(a) ADSCs were cultured for 24 h in hypoxia before being depleted for ING1b, HIF1α. Subsequently, cells were incubated with adipogenic induction medium under hypoxia.
Knockdowns and media changes were performed every 3 days. Adipocyte marker (FABP4, LPL, PPARγ2) expressions were analyzed by Q-PCR for day 7 samples.
(b) Adipogenic differentiation of ADSCs in normoxic conditions. ADSCs were knocked down every 3 days for ING1 and HIF1α under normoxic conditions during the adipogenic
induction. (c) Efficiencies of ING1b and HIF1α siRNAs were evaluated at day 7 by Q-PCR. (d) No difference in expressions of adipocyte markers is observed following ING1b
depletion at the end of 14 days of adipogenic induction, suggesting ING1b is not involved in a same manner during the adipocyte differentiation at 7 and 14 days of the adipogenic
induction. FABP4, LPL and PPARγ2 mRNA levels were evaluated by Q-PCR. All mRNA levels were normalized to U6 expression. Bars represent mean±S.E.M. Po0.05 (*),
Po0.01 (**), Po0.001 (***), non significant (NS) in an unpaired Student’s t-test (n= 3)
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conformational change.44 Overall, we showed that SUMOyla-
tion of ING1b, critical for HIF1α degradation, might require
proteins modulating SUMOylation, as PIAS4, or deSUMOyla-
tion processes.
The hypoxic response and HIF1α are critical for the
maintenance of MSC properties and their immature
state,4,45,46 and the roles of ING proteins have been
minimally studied in MSCs. Nonetheless, it seemed con-
ceivable that ING1b, because of its functions could be
involved in MSC fate. Adipogenesis has been frequently
associated with mid to high oxygen tensions. Indeed,
markers of adipocytes, like LPL or PPARγ2, have been
shown to be reduced following HIF1α activation.47,48 As a
consequence, we hypothesized that ING1b, by reducing
HIF1α protein levels could facilitate this differentiation
process. In agreement with our hypothesis, we observed
that the presence of ING1b was required for expression of
these adipocyte markers during the early/intermediate days
of the adipogenesis process (day 7), whereas HIF1α was
associated to their downregulations. Thus, we suggested
that ING1b might be involved in the adipocyte differentiation,
by decreasing the level of HIF1α in hypoxia. However, our
results do not exclude the possibility that ING1b could have
more roles in cell differentiation. Cheng et al.49 showed that
ING1, as a reader of H3K4me3 histone marks, was needed
for myoblast differentiation by promoting the expression of
myoblast-specific genes. H3K4me3 marks have been
associated with active lineage-specific promoters in ADSCs
(LPL, FABP4 and PPARγ2) during differentiation, and
interestingly HIF1α has been reported to target open
chromatin regions associated with H3K4me3.50,51 Thus,
hypoxia may constitutively repress the expression of LPL,
FABP4 and PPARγ2, through HIF1α. In addition, when
ING1b and HIF1α were both depleted, adipocyte markers
were normally expressed in hypoxic conditions, suggesting
that adipocyte markers expression were no longer modu-
lated. Thus, as for the genomic stability in hypoxia, ING1b
might be involved in differentiation processes at different
levels and may act differently according the presence of
other transcription factors. We also evaluated the levels of
DLK1/PREF-1, an early mesenchymal marker,24 at the end
of 7 days of adipogenic induction in hypoxia. Although our
culture context was prone to keep elevated levels
of DLH1/Pref-1 with probable elevated levels of HIF1α and
HIF2α proteins,52 we noticed that DLH1/Pref-1 decreased
during this adipogenic induction. Taken together, we can
conclude that the hypoxic culture context did not impede the
triggering of the adipocyte differentiation. However,
critical adipocyte markers like PPARγ2 present at more
early stages or later adipocyte markers like LPL and mostly
FABP4 have been modulated through the 14 days of
adipogenic induction. Thus, we observed that ING1 was
required for these adipocyte marker expressions under
hypoxia until day 7 of adipogenic induction. Conversely,
HIF1α, a main marker of the hypoxic response repressed
their expressions.
Finally, we propose a mechanism where ING1b may prevent
the hypoxic response, either by reducing HIF1α protein content
in the nucleus or on chromatin. As we report, expressions of
adipocyte markers (LPL, FABP4, PPARγ2) were reduced by
HIF1α in hypoxia (Figures 5a, 6a and b). Our study suggests
that HIF1α degradation, promoted by ING1b, may increase
expression levels of LPL, FABP4 and PPARγ2 (Figure 6b). As a
consequence, ING1b could potentiate the differentiation of
Figure 6 A model for ING1b-dependent degradation of HIF1α in hypoxia.
(a) HIF1α regulation in normoxic and hypoxic conditions. Under normoxic conditions
HIF1α interact with HIF prolyl hydroxylase 2 (HPH-2) and is degraded. Under hypoxic
conditions, hydroxylation of HIF1α by HPH-2 is impaired, resulting in its stabilization.
(b) In hypoxia in ADSCs or U2OS cells, PIAS4 stabilizes HIF1α in presence or
absence of ING1b and HIF1α impairs expression of adipocyte markers when
adipogenesis is induced (upper panel). Following stimulation (doxorubicin treatment
or adipogenic induction), ING1b is stabilized in a PIAS4-dependent manner (lower
panel). PIAS4 is then degraded in an ING1b-dependent manner and ING1b
subsequently promotes HIF1α proteasomal degradation and the expression of
adipocyte markers. (c) Regulation of HIF1α by ING proteins. Under hypoxic
conditions, ING4 has been demonstrated to bind the HIF1α protein complex through
interactions with HPH-2, thus preventing the transcription activity of HIF1α
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ADSCs. Moreover, ING1b can interact with histonemodifiers,
like SIRT1,53 already described to modulate HIF1α inactiva-
tion and to regulate differentiation of MSCs.54,55 Therefore,
ING1b could take part in a complex regulating MSC’s fate,
especially under low oxygen tension.
In our study, we focused on adipocyte differentiation under
hypoxic conditions. Of note, we failed to induce osteogenesis
under hypoxia with ADSCs, although other studies have
discussed the benefits of hypoxia on osteogenesis23 (data not
shown). Thus, we could not conclude on a role of ING1b in this
context. Nevertheless, we proceeded to osteogenic induction in
21%O2 (Supplementary Figure 7) and noticed that when ING1
was silenced in normoxic conditions,RUNX2, BGLAP and SP7
levels increased, as well as calcium deposits at 7 or 14 days,
suggesting that as for adipocyte marker expressions under
normoxia, ING1b might decrease osteoblast marker expres-
sions in normoxia as well. Interestingly, even if it challenged the
physiological sense, it appeared that HIF1α knockdown
enhanced osteogenesis in normoxia. This suggests that
HIF1α might be sufficiently maintained in normoxia for
modulating expression of some targets. This is in accordance
with the study byPalomäki et al.6 that demonstrated great levels
of HIF1α in normoxia in MSCs. Thus, ING1b appeared to
display various roles according to the commitment and the
culture context of ADSCs.
Conclusion
So far, ING proteins roles in hypoxia have been little studied. In
this study we focused on ING1b in a mesenchymal stromal cell
model, whose properties are particularly dependent on oxygen
tension. As depicted in the Figure 6b, ING1b, under the control of
its SUMOylation status appears to regulate the hypoxic response
by triggering the proteasomal degradation of HIF1α, which
eventually could lead to changes in its target genes expression
(VEGF and EPO). Nonetheless, the hypoxic response may be
regulated at different levels (Figure 6c) by other ING proteins, as
previous study demonstrated with ING4.12
Materials and Methods
Culture of ADSCs and induction of adipogenesis. Healthy donor
recruitment followed the institutional review board approval and written informed
consent process according to the Declaration of Helsinki. The stromal vascular
fraction (SVF) was isolated from human abdominal lipoaspirates of adults
undergoing reconstructive surgery after weight loss.56 Lipoaspirates were
centrifuged for 5 min at 600 × g. Phases containing adipocyte debris and red blood
cells were removed. Tissues were digested with type IV collagenase (200 U/ml),
neutral protease dispase (1.6 U/ml; Worthington, Freehold, NJ, USA) and DNAse
(Pulmozyme,10 U/ml, Roche, Neuilly-sur-Seine, France) for 45 min at 37 °C with
gentle rocking. Lysates were passed through a 100 μm cell strainer and centrifuged
for 10 min at 600 × g to obtain the SVF. Cells from the SVF were seeded at
1000 cells/cm2 in αMEM supplemented with 10% selected fetal calf serum
(HyClone, FCS, Thermo Scientific, Villebon sur Yvette, France), 1 ng/ml of bFGF
(Cellgenix, Clermont Ferrand, France), penicillin (100 U/ml), and streptomycin
(100 μg/ml; Life Technologies). ADSCs were analyzed for CD73, CD90, CD45 and
CD31 presences at the end of the first passage (Supplementary Figure 1). The
established ADSC primary lines were passaged at 90% of confluence and plated at
2000–2500 cells/cm2 and cultivated in αMEM supplemented with 10% selected
Hyclone FCS, 1 ng/ml of bFGF, penicillin (100 U/ml), and streptomycin (100 μg/ml).
ADSCs from three different donors were used in experiments between 15 and 20
cumulative population doublings.
Adipogenesis induction was performed using the hMSC Mesenchymal Stem Cell
Adipogenic Differentiation Medium (Lonza, Verviers, Belgium) according to the
manufacturer’s recommendations. ADSCs were cultured at 37 °C, 5% CO2 and 21 or
1% O2, in agreement with the experiment purposes. The medium was changed every
3 days and the differentiation period lasted 7 or 14 days.
U2OS oesteosarcoma cells (p53+/+) were grown in McCoy’s 5A modified medium
supplemented with 10% FCS (Life Technologies), penicillin (100 U/ml) and
streptomycin (100 μg/ml).
Cells were amplified in normoxia (5% CO2, 21% O2) at 37 °C and placed in a
Binder CB incubator (VWR International, Fontenay-sous-Bois, France) for a 24 h
buffering time before each experiment under hypoxic conditions (5% CO2, 1% O2) at
37 °C.
Transfections. Silencing experiments were performed with Lipofectamine
RNAiMAX Transfection Reagent (Life Technologies) according to the manufacturer’s
instructions. ING1b, PIAS4 stealth RNAi siRNAs (Life Technologies) and HIF1α
siRNA (SC-35561, Santa Cruz Biotechnology, CliniSciences, Nanterre, France)
were used in experiments. A Stealth RNAi siRNA Negative Control (Life
Technologies) was used as control.
Stably transfected U2OS cells were previously produced using the empty pcDNA
3.1 vector, pcDNA 3.1 ING1bWT (coding for ING1b) and pcDNA 3.1 ING1b E195 and
selected with G148 (0.5 mg/ml).15
Transient transfections with empty pcDNA 3.1 (control), pcDNA 3.1 Flag ING1b
WT plasmids were performed on ADSCs using a Human MSC Nucleofector Kit and
the Nucleofector device (Lonza).
Western blot and immunoprecipitations experiments. Protein
samples were obtained after washing cells in cold 1X PBS buffer and harvesting
in RIPA buffer containing a protease inhibitor cocktail (Roche). Supernatants were
collected after a 4 °C centrifugation at 16 000× g for 15 min. Samples were
subjected to electrophoresis using the NuPage Novex Bis-Tris Gel Electrophoresis
system (Life Technologies), and transferred to nitrocellulose membrane. The
antibodies used were anti-PIAS4, anti-HIF1α, anti-ING1b (Cab3) (Santa Cruz
Biotechnology), anti-βactin (Sigma, St Quentin Fallawier, France) and anti-gH2AX
(Cell Signaling).
After 24 h of incubation under hypoxic conditions, cells were washed in
cold 1X PBS buffer and harvested in IP lysis buffer (Thermo Fisher Scientific,
Villebon sur Yvette, France), containing a protease inhibitor cocktail. Lysates were
centrifuged at 4 °C for 15 min at 16 000× g and supernatants were recovered.
Equal amounts of protein extracts were incubated with the ING1b (Cab1 and Cab5)
or HIF1α antibodies for 3 h and then respectively bound to Dynabeads Protein G
and protein A (Life Technologies) at 4 °C with rocking. Beads were washed three
times with cold 1X PBS buffer+0.01% Tween20. Immunoprecipitated samples were
analyzed by Western blot.
Western blots pictures were obtained with a Gbox imager (Syngene, Cambridge,
UK) and were quantified using ImageJ software (U. S. National Institutes of Health,
Bethesda, MD, USA, http://imagej.nih.gov/ij/). Results display the amount of protein of
interest normalized on actin amount. Data are represented as percentages.
Quantitative RT-PCR. RNA was extracted using the RNeasy Kit (Qiagen,
Courtaboeuf, France) and cDNAs were generated using the Superscript II reverse
transcriptase (Life Technologies). RT-PCR amplification experiments were
performed with the SYBR Green PCR Master Mix on a StepOnePlus Real-Time
PCR System (Applied Biosystems, Life Technologies, Villebon sur Yvette, France).
The relative gene expression was calculated with the 2−ΔΔCT method. All the
results were normalized to U6 expression (similar results were obtained for
housekeeping genes such as RPL13a, not shown). The primer sequences used in
RT-PCR are listed in Supplementary Figure 8.
Statistical analyzes. ADSC PCR data is presented as mean± S.E.M. The
statistical significance was determined using an unpaired Student’s t-test. Values of
Po0.05 (*), Po0.01 (**) and Po0.001 (***) were considered statistically
significant. Experiments were repeated three times.
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